Abstract
Cytokinins are phytohormones that regulate plant growth, development and senescence. Experiments both in vitro and in vivo demonstrate that they can also have diverse effects on animal cells and tissues. Particularly interesting is their ability to protect cells against various forms of stress and prevent some detrimental effects of cell aging. For example, human skin fibroblasts cultured in the presence of kinetin or trans-zeatin retain some characteristics of cells of lower passage. Kinetin is even able to increase the lifespan of invertebrates. In this chapter, we review protective effects of cytokinins in animals at molecular, cellular, tissue and organismal levels. We also discuss potential application of cytokinins for the treatment of age-related diseases, including neurodegenerations, inflammatory diseases and disorders caused by aberrant cell proliferation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADK:
-
Adenosine kinase
- A2AR:
-
A2A adenosine receptor
- A3R:
-
A3R adenosine receptor
- BA:
-
N 6-benzyladenine
- BAR:
-
N 6-benzyladenosine
- ENT:
-
Equilibrative nucleoside transporter
- tZ:
-
trans-zeatin
- tZR:
-
trans-zeatin riboside
- iP:
-
N 6-isopentenyladenine
- iPR:
-
N 6-isopentenyladenosine
- ipt:
-
Isopentenyltransferase
- K:
-
Kinetin
- KR:
-
Kinetin riboside
- KRTP:
-
Kinetin riboside-5′-triphosphate
- oTR:
-
ortho-topolin riboside
- pTR:
-
para-topolin riboside
- ROS:
-
Reactive oxygen species
References
Amiable C, Pochet S, Padilla A, Labesse G, Kaminski PA (2013) N6-substituted AMPs inhibit mammalian deoxynucleotide N-hydrolase DNPH1. PLoS ONE 8:e80755. doi:10.1371/journal.pone.0080755
Barciszewski J, Siboska GE, Pedersen BO, Clark BFC, Rattan SIS (1996) Evidence for the presence of kinetin in DNA and cell extracts. FEBS 393:197–200
Barciszewski J, Siboska GE, Pedersen BO, Clark BFC, Rattan SIS (1997) A mechanism for the in vivo formation of N6-furfuryladenine, kinetin, as a secondary oxidative damage product of DNA. FEBS Lett 414:457–460. doi:10.1016/S0014-5793(97)01037-5
Barciszewski J, Mielcarek M, Stobiecki M, Siboska G, Clark BFC (2000) Identification of 6-furfuryladenine (kinetin) in human urine. Biochem Biophys Res Commun 279:69–73. doi:10.1006/bbrc.2000.3928
Berge U, Kristensen P, Rattan SIS (2006) Kinetin-induced differentiation of normal human keratinocytes undergoing aging in vitro. Ann NY Acad Sci 1067:332–336. doi:10.1196/annals.1354.045
Berge U, Kristensen P, Rattan SIS (2008) Hormetic modulation of differentiation of normal human epidermal keratinocytes undergoing replicative senescence in vitro. Exp Gerontol 43:658–662. doi:10.1016/j.exger.2007.12.009
Bifulco M, D’Alessandro A, Paladino S, Malfitano AM, Notarnicola M, Caruso MG, Laezza C (2013) N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A. FEBS J 280:6223–6232. doi:10.1111/febs.12544
Blad CC, von Frijtag Drabbe Künzel JK, de Vries H, Mulder-Krieger T, Bar-Yehuda S, Fishman P, Ijzerman AP (2011) Putative role of the adenosine A(3) receptor in the antiproliferative action of N (6)-(2-isopentenyl)adenosine. Purinergic Signal 7:453–462. doi:10.1007/s11302-011-9244-9
Borea PA, Varani K, Vincenzi F, Baraldi PG, Tabrizi MA, Merighi S, Gessi S (2014) The A3 adenosine receptor: history and perspectives. Pharmacol Rev 67:74–102. doi:10.1124/pr.113.008540
Brizzolari A, Marinello C, Carini M, Santaniello E, Biondi PA (2016) Evaluation of the antioxidant activity and capacity of some natural N6-substituted adenine derivatives (cytokinins) by fluorimetric and spectrophotometric assays. J Chromatogr B: Anal Technol Biomed Life Sci 1019:164–168. doi:10.1016/j.jchromb.2015.12.047
Bruns DR, Drake JC, Biela LM, Peelor FF, Miller BF, Hamilton KL (2015) Nrf2 signaling and the slowed aging phenotype: evidence from long-lived models. Oxid Med Cell Longev 2015:1–15. doi:10.1155/2015/732596
Cabello CM, Bair WB 3rd, Ley S, Lamore SD, Azimian S, Wondrak GT (2009) The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines. Biochem Pharmacol 77:1125–1138. doi:10.1016/j.bcp.2008.12.002
Carimi F, Zottini M, Formentin E, Terzi M, Lo Schiavo F (2003) Cytokinins: new apoptotic inducers in plants. Planta 216:413–421. doi:10.1007/s00425-002-0862-x
Chen C, Kristopeit SM (1981) Metabolism of cytokinin: deribosylation of cytokinin ribonucleoside by adenosine nucleosidase from wheat germ cells. Plant Physiol 68:1020–1023. doi:10.1104/pp.68.5.1020
Cheong J, Goh D, Yong JWH, Tan SN, Ong ES (2009) Inhibitory effect of kinetin riboside in human heptamoa, HepG2. Mol BioSyst 5:91–98. doi:10.1039/b712807j
Chhabra P, Linden J, Lobo P, Okusa MD, Brayman KL (2012) The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation. Curr Diabetes Rev 8:419–433
Chheda G, Mittelman A (1972) N6-(Δ2-isopentenyl) adenosine metabolism in man. Biochem Pharmacol 21:27–37
Chiu P-C, Chan C-C, Lin H-M, Chiu H-C (2007) The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial. J Cosmet Dermatol 6:243–249. doi:10.1111/j.1473-2165.2007.00342.x
Chiu F-L, Lin J-T, Chuang C-Y, Chien T, Chen C-M, Chen K-H, Hsiao H-Y, Lin Y-S, Chern Y, Kuo H-C (2015) Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington’s disease iPSCs. Hum Mol Genet 24:6066–6079. doi:10.1093/hmg/ddv318
Choi SJ, Jeong C-H, Choi S-G, Chun J-Y, Kim YJ, Lee J, Shin D-H, Heo HJ (2009) Zeatin prevents amyloid beta-induced neurotoxicity and scopolamine-induced cognitive deficits. J Med Food 12:271–277. doi:10.1089/jmf.2007.0678
Chou S-Y, Lee Y-C, Chen H-M, Chiang M-C, Lai H-L, Chang H-H, Wu Y-C, Sun C-N, Chien C-L, Lin Y-S, Wang S-C, Tung Y-Y, Chang C, Chern Y (2005) CGS21680 attenuates symptoms of Huntington’s disease in a transgenic mouse model. J Neurochem 93:310–320. doi:10.1111/j.1471-4159.2005.03029.x
Ciaglia E, Pisanti S, Picardi P, Laezza C, Sosa S, Tubaro A, Vitale M, Gazzerro P, Malfitano AM, Bifulco M (2014) N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice. Pharmacol Res 89:1–10. doi:10.1016/j.phrs.2014.07.003
Ciaglia E, Abate M, Laezza C, Pisanti S, Vitale M, Seneca V, Torelli G, Franceschelli S, Catapano G, Gazzerro P, Bifulco M (2016) Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. Int J Cancer. doi:10.1002/ijc.30505
Colombo F, Falvella FS, De Cecco L, Tortoreto M, Pratesi G, Ciuffreda P, Ottria R, Santaniello E, Cicatiello L, Weisz A, Dragani TA (2009) Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine. Int J Cancer 124:2179–2185. doi:10.1002/ijc.24168
Dassano A, Mancuso M, Giardullo P, De Cecco L, Ciuffreda P, Santaniello E, Saran A, Dragani TA, Colombo F (2014) N(6)-isopentenyladenosine and analogs activate the NRF2-mediated antioxidant response. Redox Biol 2:580–589. doi:10.1016/j.redox.2014.03.001
David M, Gospodinov DK, Gheorghe N, Mateev GS, Rusinova MV, Hristakieva E, Solovastru LG, Patel RV, Giurcaneanu C, Hitova MC, Purcaru AI, Horia B, Tsingov II, Yankova RK, Kadurina MI, Ramon M, Rotaru M, Simionescu O, Benea V, Demerdjieva ZV, Cosgarea MR, Morariu HS, Michael Z, Cristodor P, Nica C, Silverman MH, Bristol DR, Harpaz Z, Farbstein M, Cohen S, Fishman P (2016) Treatment of plaque-type psoriasis with oral CF101: data from a phase II/III multicenter, randomized, controlled trial. J Drugs Dermatol 15:931–938
Doležal K, Popa I, Hauserová E, Spíchal L, Chakrabarty K, Novák O, Kryštof V, Voller J, Holub J, Strnad M (2007) Preparation, biological activity and endogenous occurrence of N6-benzyladenosines. Bioorg Med Chem 15:3737–3747. doi:10.1016/j.bmc.2007.03.038
Gan S, Amasino RM (1995) Inhibition of leaf senescence by autoregulated production of cytokinin. Science 270:1986–1988. doi:10.1126/science.270.5244.1986
Ge L, Yong JWH, Tan SN, Yang XH, Ong ES (2004) Analysis of some cytokinins in coconut (Cocos nucifera L.) water by micellar electrokinetic capillary chromatography after solid-phase extraction. J Chromatogr A 1048:119–126
Gillissen B, Burkle L, Andre B, Kuhn C, Rentsch D, Brandl B, Frommer WB (2000) A new family of high-affinity transporters for adenine, cytosine, and purine derivatives in Arabidopsis. Plant Cell 12:291–300. doi:10.1105/tpc.12.2.291
Goldstein S, Czapski G (1991) SOD-like activity studies of cytokinin-copper(II) complexes. Free Radic Res Commun 12–13(Pt 1):173–177. doi:10.3109/10715769109145783
Griffaut B, Bos R, Maurizis J-CC, Madelmont J-CC, Ledoigt G (2004) Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells. Int J Biol Macromol 34:271–275. doi:10.1016/j.ijbiomac.2004.06.004
Haider S, Tabassum S, Perveen T (2016) Scopolamine-induced greater alterations in neurochemical profile and increased oxidative stress demonstrated a better model of dementia: a comparative study. Brain Res Bull 127:234–247. doi:10.1016/j.brainresbull.2016.10.002
Havlíček L, Hanuš J, Veselý J, Leclerc S, Meijer L, Shaw G, Strnad M (1997) Cytokinin-derived cyclizn-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem 40:408–412. doi:10.1021/jm960666x
Heo H-J, Hong S-C, Cho H-Y, Hong B, Kim H-K, Kim E-K, Shin D-H (2002) Inhibitory effect of zeatin, isolated from Fiatoua villosa, on acetylcholinesterase activity from PC12 cells. Mol Cells 13:113–117
Hertz NT, Berthet A, Sos ML, Thorn KS, Burlingame AL, Nakamura K, Shokat KM (2013) A neo-substrate that amplifies catalytic activity of Parkinson’s-disease-related kinase PINK1. Cell 154:737–747. doi:10.1016/j.cell.2013.07.030
Hirose N, Takei K, Kuroha T, Kamada-Nobusada T, Hayashi H, Sakakibara H (2008) Regulation of cytokinin biosynthesis, compartmentalization and translocation. J Exp Bot 59:75–83. doi:10.1093/jxb/erm157
Horgan R, Hewett EW, Horgan JM, Purse J, Wareing PF (1975) A new cytokinin from Populus x robusta. Phytochemistry 14:1005–1008. doi:10.1016/0031-9422(75)85176-4
Hsiao G, Shen M-Y, Lin K-H, Chou C-Y, Tzu N-H, Lin C-H, Chou D-S, Chen T-F, Sheu J-R (2003) Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo. Eur J Pharmacol 465:281–287. doi:10.1016/S0014-2999(03)01528-0
Huang C-L, Yang J-M, Wang K-C, Lee Y-C, Lin Y-L, Yang Y-C, Huang N-K (2011a) Gastrodia elata prevents huntingtin aggregations through activation of the adenosine A2A receptor and ubiquitin proteasome system. J Ethnopharmacol 138:162–168. doi:10.1016/j.jep.2011.08.075
Huang N-K, Lin J-H, Lin J-T, Lin C-I, Liu EM, Lin C-J, Chen W-P, Shen Y-C, Chen H-M, Chen J-B, Lai H-L, Yang C-W, Chiang M-C, Wu Y-S, Chang C, Chen J-F, Fang J-M, Lin Y-L, Chern Y (2011b) A new drug design targeting the adenosinergic system for Huntington’s disease. PLoS ONE 6:e20934. doi:10.1371/journal.pone.0020934
Ishii Y, Hori Y, Sakai S, Honma Y (2002) Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones. Cell Growth Differ 13:19–26
Ishii Y, Kasukabe T, Honma Y (2005a) Induction of CCAAT/enhancer binding protein-δ by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells. Br J Haematol 128:540–547. doi:10.1111/j.1365-2141.2004.05326.x
Ishii Y, Kasukabe T, Honma Y (2005b) Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells. Biochim Biophys Acta Mol Cell Res 1745:156–165. doi:10.1016/j.bbamcr.2005.01.005
Ji C, Yang Y, Yang B, Xia J, Sun W, Su Z, Yu L, Shan S, He S, Cheng L, Wan Y, Bi Z (2010) Trans-Zeatin attenuates ultraviolet induced down-regulation of aquaporin-3 in cultured human skin keratinocytes. Int J Mol Med 26:257–263. doi:10.3892/ijmm-00000460
Jones KR, Kang EM (2015) Graft versus host disease: new insights into A2A receptor agonist therapy. Comput Struct Biotechnol J 13:101–105. doi:10.1016/j.csbj.2014.12.003
Jorda R, Paruch K, Krystof V (2012) Cyclin-dependent kinase inhibitors inspired by roscovitine: purine bioisosteres. Curr Pharm Des 18:2974–2980
Kim S, Lee JJ, Jung E, Lee JJ, Huh S, Hwang H, Kim Y, Park D (2009) 6-Benzylaminopurine stimulates melanogenesis via cAMP-independent activation of protein kinase A. Arch Dermatol Res 301:253–258. doi:10.1007/s00403-008-0924-4
Kimura T, Doi K (2004) Depigmentation and rejuvenation effects of kinetin on the aged skin of hairless descendants of Mexican hairless dogs. Rejuvenation Res 7:32–39. doi:10.1089/154916804323105062
Kryštof V, Lenobel R, Havlíček L, Kuzma M, Strnad M (2002) Synthesis and biological activity of olomoucine II. Bioorg Med Chem Lett 12:3283–3286
Kudo T, Kiba T, Sakakibara H (2010) Metabolism and long-distance translocation of cytokinins. J Integr Plant Biol 52:53–60. doi:10.1111/j.1744-7909.2010.00898.x
Kurakawa T, Ueda N, Maekawa M, Kobayashi K, Kojima M, Nagato Y, Sakakibara H, Kyozuka J (2007) Direct control of shoot meristem activity by a cytokinin-activating enzyme. Nature 445:652–655. doi:10.1038/nature05504
Laezza C, Notarnicola M, Caruso MG, Messa C, Macchia M, Bertini S, Minutolo F, Portella G, Fiorentino L, Stingo S, Bifulco M (2006) N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation. FASEB J Off Publ Fed Am Soc Exp Biol 20:412–418. doi:10.1096/fj.05-4044lsf
Laezza C, Caruso MG, Gentile T, Notarnicola M, Malfitano AM, Di Matola T, Messa C, Gazzerro P, Bifulco M (2009) N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. Int J Cancer 124:1322–1329. doi:10.1002/ijc.24056
Laezza C, Malfitano AM, Di Matola T, Ricchi P, Bifulco M (2010) Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells. Mol Carcinog 49:892–901. doi:10.1002/mc.20666
Lappas CM (2015) The plant hormone zeatin riboside inhibits T lymphocyte activity via adenosine A2A receptor activation. Cell Mol Immunol 12:107–112. doi:10.1038/cmi.2014.33
Lee Y-C, Yang Y-C, Huang C-L, Kuo T-Y, Lin J-H, Yang D-M, Huang N-K (2012) When cytokinin, a plant hormone, meets the adenosine A2A receptor: a novel neuroprotectant and lead for treating neurodegenerative disorders? PLoS ONE 7:e38865. doi:10.1371/journal.pone.0038865
Liu Y, Zhang Z, Yang X (2011) Kinetin protects against lipid peroxidation and improves antioxidant status in cultured astrocytes and mouse brain exposed to d-galactose. Afric J Biotech 10:11721–11727. doi:10.5897/AJB11.289
Luo C, Yi B, Tao G, Li M, Chen Z, Tang W, Zhang JH, Feng H (2010) Adenosine A3 receptor agonist reduces early brain injury in subarachnoid haemorrhage. NeuroReport 21:892–896. doi:10.1097/WNR.0b013e32833dbd13
Madeo F, Zimmermann A, Maiuri MC, Kroemer G (2015) Essential role for autophagy in life span extension. J Clin Invest 125:85–93. doi:10.1172/JCI73946
Maria Pugliese A, Coppi E, Volpini R, Cristalli G, Corradetti R, Jeong LS, Jacobson KA, Pedata F (2007) Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen–glucose deprivation episodes of different duration. Biochem Pharmacol 74:768–779. doi:10.1016/j.bcp.2007.06.003
McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K (2007) The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS ONE 2:e1269. doi:10.1371/journal.pone.0001269
McCullough JL, Weinstein GW (2002) Clinical study of safety and efficacy of using topical kinetin 0.10% (Kinerase) to treat photodamaged skin. Cosmet Dermatol 15(9):29–32
McCullough JL, Garcia RL, Reece B (2008) A clinical study of topical Pyratine 6 for improving the appearance of photodamaged skin. J Drugs Dermatol JDD 7:131–135
McCullough JL, Weinstein GW (2002) Clinical study to assess the safety and efficacy of topical kinetin 0.10% (Kinerase®) for photodamaged skin. Cosmet Dermatol 15:29–32
McDaniel DH, Neudecker BA, DiNardo JC, Lewis JA 2nd, Maibach HI (2005) Idebenone: a new antioxidant—Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants. J Cosmet Dermatol 4:10–17. doi:10.1111/j.1473-2165.2005.00152.x
Mcdermott SP, Eppert K, Notta F, Isaac M, Datti A, Al-awar R, Minden MD, Dick JE, Dc W, Wrana J (2012) A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of ki. Blood 119:1200–1207. doi:10.1182/blood-2011-01-330019
Meisel H, Günther S, Martin D, Schlimme E (1998) Apoptosis induced by modified ribonucleosides in human cell culture systems. FEBS Lett 433:265–268
Milne GR, Palmer TM (2011) Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor. Sci World J 11:320–339. doi:10.1100/tsw.2011.22
Mittelman A, Evans JT, Chheda GB (1975) Cytokinins as chemotherapeutic agents. Ann NY Acad Sci 255:225–234
Mlejnek P, Doležel P (2005) Apoptosis induced by N6-substituted derivatives of adenosine is related to intracellular accumulation of corresponding mononucleotides in HL-60 cells. Toxicol In Vitro 19:985–990. doi:10.1016/j.tiv.2005.06.023
Mlejnek P, Kuglík P (2000) Induction of apoptosis in HL-60 cells by N6-benzyladenosine. J Cell Biochem 77:6–17. doi:10.1002/(SICI)1097-4644(20000401)77:1<6:AID-JCB2>3.0.CO;2-3
Mlejnek P, Procházka S (2002) Activation of caspase-like proteases and induction of apoptosis by isopentenyladenosine in tobacco BY-2 cells. Planta 215:158–166. doi:10.1007/s00425-002-0733-5
Mok DWS, Mok MC (2001) Cytokinin metabolism and action. Annu Rev Plant Physiol Plant Mol Biol 52:89–118
Olsen A, Siboska GE, Clark BF, Rattan SI (1999) N(6)-Furfuryladenine, kinetin, protects against Fenton reaction-mediated oxidative damage to DNA. Biochem Biophys Res Commun 265:499–502. doi:10.1006/bbrc.1999.1669
Ortiz A, Elkeeb L, Truitt A, Hindiyeh R, Aquino L, Tran M, Weinstein G (2009) Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea. J Drugs Dermatol JDD 8:459–462
Ottria R, Casati S, Maier JAM, Mariotti M, Ciuffreda P (2009) Novel isopentenyladenosine analogues: synthesis, characterization, and evaluation of antiproliferative activity on bladder carcinoma cells. nucleosides, nucleotides and nucleic acids 28:736–751. doi:10.1080/15257770903155550
Pisanti S, Picardi P, Ciaglia E, Margarucci L, Ronca R, Giacomini A, Malfitano AM, Casapullo A, Laezza C, Gazzerro P, Bifulco M (2014) Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. FASEB J 28:1132–1144. doi:10.1096/fj.13-238238
Rajabi M, Gorincioi E, Santaniello E (2012) Antiproliferative activity of kinetin riboside on HCT-15 colon cancer cell line. Nucleosides Nucleotides Nucleic Acids 31:474–481. doi:10.1080/15257770.2012.681825
Rattan SI, Clark BF (1994) Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun 201:665–672
Rattan SIS, Sodagam L (2005) Gerontomodulatory and youth-preserving effects of zeatin on human skin fibroblasts undergoing aging in vitro. Rejuvenation Res 8:46–57. doi:10.1089/rej.2005.8.46
Sharma SP, Kaur P, Rattan SI (1995) Plant growth hormone kinetin delays ageing, prolongs the lifespan and slows down development of the fruitfly Zaprionus paravittiger. Biochem Biophys Res Commun 216:1067–1071. doi:10.1006/bbrc.1995.2729
Sharma SP, Kaur J, Rattan SI (1997) Increased longevity of kinetin-fed Zaprionus fruitflies is accompanied by their reduced fecundity and enhanced catalase activity. Biochem Mol Biol Int 41:869–875. doi:10.1080/15216549700201911
Skoog F, Strong FM, Miller CO (1965) Cytokinins. Science 148:532–533. doi:10.1126/science.148.3669.532-a
Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hims MM, Quintero F, Axelrod FB, Gusella JF (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13:429–436. doi:10.1093/hmg/ddh046
Spíchal L, Rakova NY, Riefler M, Mizuno T, Romanov GA, Strnad M, Schmülling T (2004) Two cytokinin receptors of Arabidopsis thaliana, CRE1/AHK4 and AHK3, differ in their ligand specificity in a bacterial assay. Plant Cell Physiol 45:1299–1305. doi:10.1093/pcp/pch132
Spinola M, Colombo F, Falvella FS, Dragani TA (2007) N6-isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers. Int J Cancer 120:2744–2748. doi:10.1002/ijc.22601
Štarha P, Trávníček Z, Herchel R, Popa I, Suchý P, Vančo J (2009) Dinuclear copper(II) complexes containing 6-(benzylamino)purines as bridging ligands: synthesis, characterization, and in vitro and in vivo antioxidant activities. J Inorg Biochem 103:432–440. doi:10.1016/j.jinorgbio.2008.12.009
Strnad M (1997) The aromatic cytokinins. Physiol Plant 101:674–688. doi:10.1111/j.1399-3054.1997.tb01052.x
Tiedemann RE, Mao X, Shi C-X, Zhu YX, Palmer SE, Sebag M, Marler R, Chesi M, Fonseca R, Bergsagel PL, Schimmer AD, Stewart AK (2008) Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. J Clin Invest 118:1750–1764. doi:10.1172/JCI34149
Tournas JA, Lin F-H, Burch JA, Selim MA, Monteiro-Riviere NA, Zielinski JE, Pinnell SR (2006) Ubiquinone, idebenone, and kinetin provide ineffective photoprotection to skin when compared to a topical antioxidant combination of vitamins C and E with ferulic acid. J Invest Dermatol 126:1185–1187. doi:10.1038/sj.jid.5700232
Tremaine AM, Ortiz A, Elkeeb L, Tran M, Weinstein G (2010) Long-term efficacy and safety of topical PRK 124 (0.125%) lotion (Pyratine-XR) in the treatment of mild-to-moderate rosacea. J drugs dermatology JDD 9:647–650
van der Hoeven D, Gizewski ET, Auchampach JA (2010) Activation of the A3 adenosine receptor inhibits fMLP-induced Rac activation in mouse bone marrow neutrophils. Biochem Pharmacol 79:1667–1673. doi:10.1016/j.bcp.2010.02.002
Verbeke P, Siboska GE, Clark BF, Rattan SI (2000) Kinetin inhibits protein oxidation and glycoxidation in vitro. Biochem Biophys Res Commun 276:1265–1270. doi:10.1006/bbrc.2000.3616
Vermeulen K, Strnad M, Kryštof V, Havlíček L, Van der Aa A, Lenjou M, Nijs G, Rodrigus I, Stockman B, van Onckelen H, Van Bockstaele DR, Berneman ZN (2002) Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases. Leuk Off J Leuk Soc Am Leuk Res Fund UK 16:299–305. doi:10.1038/sj.leu.2402378
Veselý J, Havlíček L, Strnad M, Blow JJ, Donella-Deana A, Pinna L, Letham DS, Kato J, Detivaud L, Leclerc S (1994) Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem 224:771–786. doi:10.1111/j.1432-1033.1994.00771.x
Vičanová J, Bouez C, Lacroix S, Lindmark L, Damour O (2006) Epidermal and dermal characteristics in skin equivalent after systemic and topical application of skin care ingredients. Ann NY Acad Sci 1067:337–342. doi:10.1196/annals.1354.046
Voller J, Zatloukal M, Lenobel R, Doležal K, Béres T, Kryštof V, Spíchal L, Niemann P, Džubák P, Hajdúch M, Strnad M (2010) Anticancer activity of natural cytokinins: a structure-activity relationship study. Phytochemistry 71:1350–1359. doi:10.1016/j.phytochem.2010.04.018
Voller J, Béres T, Zatloukal M, Kaminski PA, Niemann P, Doležal K, Džubák P, Hajdúch M, Strnad M (2017) The natural cytokinin 2OH3MeOBAR induces cell death by a mechanism that is different from that of the “classical” cytokinin ribosides. Phytochemistry. doi:10.1016/j.phytochem.2017.01.004
Walla J, Szücová L, Císařová I, Gucký T, Zatloukal M, Doležal K, Greplová J, Massino FJ, Strnad M (2010) X-ray structure, NMR and stability-in-solution study of 6-(furfurylamino)-9-(tetrahydropyran-2-yl)purine—a new active compound for cosmetology. J Mol Struct 975(1–3):376–380
Wang L, Sun C, Wang Z-H, Guo G-Q (2012) Mechanism of apoptotosis induced by ortho-topolin riboside in human hepatoma cell line SMMC-7721. Food Chem Toxicol 50:1962–1968. doi:10.1016/j.fct.2012.03.053
Wanitphakdeedecha R, Meeprathom W, Manuskiatti W (2015) Efficacy and safety of 0.1% kinetin cream in the treatment of photoaging skin. Indian J Dermatol Venereol Leprol 81:547. doi:10.4103/0378-6323.157446
Werner T, Schmülling T (2009) Cytokinin action in plant development. Curr Opin Plant Biol 12(5):527–538. doi:10.1016/j.pbi.2009.07.002
Wu JJ, Weinstein GD, Kricorian GJ, Kormeili T, McCullough JL (2007) Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol 32:693–695. doi:10.1111/j.1365-2230.2007.02513.x
Yang B, Ji C, Kang J, Chen W, Bi Z, Wan Y (2009) Trans-zeatin inhibits UVB-induced matrix metalloproteinase-1 expression via MAP kinase signaling in human skin fibroblasts. Int J Mol Med 23:555–560
Zhang K, Novak O, Wei Z, Gou M, Zhang X, Yu Y, Yang H, Cai Y, Strnad M, Liu C-J (2014) Arabidopsis ABCG14 protein controls the acropetal translocation of root-synthesized cytokinins. Nat Commun 5:3274. doi:10.1038/ncomms4274
Zwack PJ, Rashotte AM (2013) Cytokinin inhibition of leaf senescence. Plant Signal Behav 8:e24737. doi:10.4161/psb.24737
Acknowledgements
The study was partly supported by the Internal Grant Agency of Palacký University (IGA_PrF_2017_013), Endowment Fund of Palacký University and by the Grant Agency of the Czech Republic (7-14007S). This work was also funded by the Ministry of Education, Youth and Sports of the Czech Republic (the National Program for Sustainability I: Nr. LO1204).
The authors also would like to thank Sees-editing Ltd. (UK) for the English editing of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Voller, J., Maková, B., Kadlecová, A., Gonzalez, G., Strnad, M. (2017). Plant Hormone Cytokinins for Modulating Human Aging and Age-Related Diseases. In: Rattan, S., Sharma, R. (eds) Hormones in Ageing and Longevity. Healthy Ageing and Longevity, vol 6. Springer, Cham. https://doi.org/10.1007/978-3-319-63001-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-63001-4_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-63000-7
Online ISBN: 978-3-319-63001-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)